GWM
CVS icon

Geneos Wealth Management’s CVS Health CVS Stock Holding History

Geneos Wealth Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$778K Buy
10,828
+3,313
+44% +$255K 0.02% 568
2025
Q4 		$596K Buy
7,515
+1,593
+27% +$126K 0.01% 619
2025
Q3 		$446K Sell
5,922
-2,628
-31% -$180K 0.01% 683
2025
Q2 		$590K Sell
8,550
-7,527
-47% -$494K 0.01% 662
2025
Q1 		$1.09M Buy
16,077
+10,320
+179% +$618K 0.02% 639
2024
Q4 		$258K Sell
5,757
-57,711
-91% -$3.24M 0.01% 757
2024
Q3 		$3.99M Buy
63,468
+9,231
+17% +$539K 0.15% 160
2024
Q2 		$3.2M Sell
54,237
-12,755
-19% -$798K 0.14% 170
2024
Q1 		$5.34M Sell
66,992
-483
-0.7% -$36.9K 0.24% 98
2023
Q4 		$5.33M Sell
67,475
-15,047
-18% -$1.07M 0.26% 93
2023
Q3 		$5.76M Buy
82,522
+4,733
+6% +$335K 0.3% 80
2023
Q2 		$5.38M Buy
77,789
+14,953
+24% +$1.06M 0.28% 86
2023
Q1 		$4.67M Sell
62,836
-4,627
-7% -$388K 0.28% 89
2022
Q4 		$6.29M Buy
67,463
+13,815
+26% +$1.33M 0.38% 57
2022
Q3 		$5.12M Sell
53,648
-3,915
-7% -$388K 0.35% 64
2022
Q2 		$5.41M Buy
57,563
+2,058
+4% +$201K 0.27% 90
2022
Q1 		$5.62M Sell
55,505
-6,370
-10% -$669K 0.24% 95
2021
Q4 		$6.39M Sell
61,875
-14,118
-19% -$1.3M 0.24% 95
2021
Q3 		$6.39M Buy
75,993
+648
+0.9% +$54.3K 0.24% 95
2021
Q2 		$6.21M Sell
75,345
-9,505
-11% -$778K 0.24% 94
2021
Q1 		$6.48M Buy
84,850
+691
+0.8% +$50.3K 0.18% 134
2020
Q4 		$5.98M Buy
84,159
+878
+1% +$57.1K 0.24% 95
2020
Q3 		$4.78M Sell
83,281
-15,203
-15% -$946K 0.25% 93
2020
Q2 		$6.25M Buy
98,484
+1,585
+2% +$99.8K 0.35% 68
2020
Q1 		$5.68M Buy
96,899
+2,315
+2% +$155K 0.38% 57
2019
Q4 		$7.04M Buy
94,584
+5,503
+6% +$386K 0.38% 58
2019
Q3 		$5.53M Sell
89,081
-2,876
-3% -$170K 0.33% 76
2019
Q2 		$5.01M Buy
91,957
+12,761
+16% +$687K 0.31% 84
2019
Q1 		$4.27M Sell
79,196
-713
-0.9% -$44K 0.28% 90
2018
Q4 		$5.21M Sell
79,909
-357
-0.4% -$26.6K 0.39% 59
2018
Q3 		$6.32M Buy
80,266
+66,648
+489% +$4.76M 0.42% 50
2018
Q2 		$876K Buy
13,618
+86
+0.6% +$5.67K 0.07% 242
2018
Q1 		$841K Sell
13,532
-779
-5% -$55.9K 0.07% 238
2017
Q4 		$1.04M Buy
14,311
+1,803
+14% +$131K 0.09% 206
2017
Q3 		$1.02M Buy
12,508
+144
+1% +$11.4K 0.1% 196
2017
Q2 		$994K Sell
12,364
-545
-4% -$43K 0.1% 190
2017
Q1 		$1.01M Sell
12,909
-779
-6% -$62.2K 0.11% 175
2016
Q4 		$1.08M Sell
13,688
-425
-3% -$34.4K 0.14% 150
2016
Q3 		$1.25M Buy
14,113
+478
+4% +$45.1K 0.17% 133
2016
Q2 		$1.29M Buy
13,635
+10
+0.1% +$997 0.19% 120
2016
Q1 		$1.43M Buy
+13,625
New +$1.32M 0.22% 112

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geneos Wealth Management's CVS Position: Q1 2026 in Review

Geneos Wealth Management increased its CVS Health (CVS) stake by 44% in Q1 2026, buying an estimated $255K and bringing the position to 10,828 shares worth $778K. The position accounts for 0.02% of the portfolio, ranked #568.

Geneos Wealth Management first reported a position in CVS in Q1 2016 and has held it in 41 quarters since. The position peaked at $7.04M in Q4 2019. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Geneos Wealth Management held 10,828 shares of CVS Health worth $778K as of Q1 2026.
  • Geneos Wealth Management bought 3,313 CVS Health shares in Q1 2026, an estimated $255K.
  • CVS Health made up 0.02% of Geneos Wealth Management's portfolio in Q1 2026, its #568 holding.
  • Geneos Wealth Management first reported a position in CVS Health in Q1 2016 and has held it in 41 quarters since.
  • Geneos Wealth Management's CVS Health position peaked at $7.04M in Q4 2019.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.